560 related articles for article (PubMed ID: 2788339)
1. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
2. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
3. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
4. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
5. Involvement of complement in atopic dermatitis.
Kapp A; Schöpf E
Acta Derm Venereol Suppl (Stockh); 1985; 114():152-4. PubMed ID: 3923750
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
7. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
8. Anaphylatoxin levels in human vitreous humor.
Mondino BJ; Sidikaro Y; Sumner H
Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
[TBL] [Abstract][Full Text] [Related]
9. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
10. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
11. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
Kapp A; Wokalek H; Schöpf E
Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
13. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
[TBL] [Abstract][Full Text] [Related]
14. Serum complement levels and severity of sepsis.
Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
16. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
[No Abstract] [Full Text] [Related]
17. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
[TBL] [Abstract][Full Text] [Related]
18. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
20. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
Wolach B; Coates TD; Hugli TE; Baehner RL; Boxer LA
J Lab Clin Med; 1984 Feb; 103(2):284-93. PubMed ID: 6607301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]